A statistical study of the American Urological Association symptom index for benign prostatic hyperplasia in participants of mass screening program for prostatic diseases using transrectal sonography

Journal of Urology

Volumn 156, Issue 5, 1996, Pages 1673-1678

  Ukimura, O ^a   Kojima, M ^a   Inui, E ^a   Ochiai, A ^a   Hata, Y ^a   Watanabe, M ^a   Saitoh, M ^a   Watanabe, H ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

aging; prostate; prostatic hypertrophy; ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEDICAL SOCIETY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; STATISTICAL ANALYSIS; SYMPTOM; TRANSRECTAL ULTRASONOGRAPHY;

EID: 0029902803     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)65480-6     Document Type: Article

References (24)

1. Barry, M. J., Fowler, F. J., Jr., O'Leary, M. P., Bruskewitz, R. C., Holtgrewe, H. L., Mebust, W. K. and Cockett, A. T. K.: The American Urological Association symptom index for benign prostatic hyperplasia. J. Urol., 148: 1549, 1992.
2. Chai, T. C., Belville, W. D., McGuire, E. J. and Nyquist, L.: Specificity of the American Urological Association voiding symptom index: comparison of unselected and selected samples of both sexes. J. Urol., part 2, 150: 1710, 1993.
3. Lepor, H. and Machi, G.: Comparison of AUA symptom index in unselected males and females between fifty-five and seventy-nine years of age. Urology, 42: 36, 1993.
4. Chancellor, M. B. and Rivas, D. A.: American Urological Association symptom index for women with voiding symptoms: lack of index specificity for benign prostate hyperplasia. J. Urol., part 2, 150: 1706, 1993.
5. Chancellor, M. B., Rivas, D. A., Keeley, F. X., Lotfi, M. A. and Gomella, L. G.: Similarity of the American Urological Association symptom index among men with benign prostate hyperplasia (BPH), urethral obstruction not due to BPH and detrusor hyperreflexia without outlet obstruction. Brit. J. Urol., 74: 200, 1994.
6. Watanabe, H., Kato, H., Kato, T., Morita, M., Tanaka, M. and Terasawa, Y.: Diagnostic application of the ultrasonotomography to the prostate. Jap. J. Urol., 59: 273, 1968.
7. Watanabe, H., Igari, D., Tanahashi, Y., Harada, K. and Saitoh, M.: Transrectal ultrasonotomography of the prostate. J. Urol., 114: 734, 1975.
8. Watanabe, H.: Natural history of benign prostatic hypertrophy. Ultrasound Med. Biol., 127: 567, 1986.
9. Watanabe, H.: Transrectal sonography. A personal review and recent advances. Scand. J. Urol. Nephrol., suppl., 137: 75, 1991.
10. Watanabe, H., Saitoh, M., Mishina, T., Igari, D., Tanahashi, Y., Harada, K. and Hisamichi, S.: Mass screening program for prostatic diseases with transrectal ultrasonotomography. J. Urol., 117: 746, 1977.
11. Watanabe, H., Ohe, H., Inaba, H., Itakura, Y., Saitoh, M. and Nakao, M.: A mobile mass screening unit for prostatic disease. Prostate, 5: 559, 1984.
12. Watanabe, H., Ohe, H., Saitoh, M., Kojima, M., Tanaka, T. and Ito, S.: PSA assay of dried blood samples from the ear lobe on a filter paper with special reference to prostatic mass screening. Prostate, 27: 90, 1995.
13. Kawabe, K. and Watanabe, H.: Manual of benign prostatic hyperplasia. New Remedies & Therapy, 44: 13, 1994.
14. Japanese Urological Association and The Japanese Pathological Society: General Rule for Clinical and Pathological Studies on Prostatic Cancer, 2nd ed. Tokyo: Kanahara, p. 1, 1992.
15. Norman, R. W., Nickel, J. C., Fish, D. and Pickett, S. N.: 'Prostate-related symptoms' in Canadian men 50 years of age or older: prevalence and relationships among symptoms. Brit. J. Urol., 74: 542, 1994.
16. Chute, C. G., Panser, L. A., Girman, C. J., Oesterling, J. E., Guess, H. A., Jacobsen, S. J. and Lieber, M. M.: The prevalence of prostatism: a population-based survey of urinary symptoms. J. Urol., 150: 85, 1993.
17. Bosch, J. L. H. R., Hop, W. C. J., Kirkels, W. J. and Schröder, F. H.: The international prostate symptom score in a community-based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Brit. J. Urol., 75: 622, 1995.
18. Sagnier, P.-P., Macfarlane, G., Richard, F., Botto, H., Teillac, P. and Boyle, P.: Results of an epidemiological survey using a modified American Urological Association symptom index for benign prostatic hyperplasia in France. J. Urol., 151: 1266, 1994.
19. Berry, S. J., Coffey, D. S., Walsh, P. C. and Ewing, L. L.: The development of human benign prostatic hyperplasia with age. J. Urol., 132: 474, 1984.
20. Garraway, W. M., Collins, G. N. and Lee, R. J.: High prevalence of benign prostatic hypertrophy in the community. Lancet, 338: 469, 1991.
21. Ohe, H.: Benign prostatic hypertrophy. In: Diagnostic Ultrasound in Urology and Nephrology. Edited by H. Watanabe, J. H. Holmes, H. H. Holm and B. B. Goldberg. New York: Igaku-Shoin, pp. 123-129, 1981.
22. McConnell, J. D., Barry, M. J., Bruskewiz, R. C., Bueschen, A. J., Denton, S. E., Holtgrewe, H. L., Lange, J. L., McClennan, B. L., Mebust, W. K., Reilly, N. J., Roberts, R. G., Sacks, S. A. and Wasson, J. H.: Benign Prostatic Hyperplasia: Diagnosis and Treatment. Rockville, Maryland: United States Department of Health and Human Services, p. 20, 1994.
23. Kojima, M., Ohnishi, K., Ohe, H. and Watanabe, H.: Transrectal ultrasonotomography and urethral pressure profile in benign prostatic hypertrophy. Jap. J. Urol., 75: 1406, 1984.
24. Watanabe, H.: Diagnosis of benign prostatic hypertrophy by ultrasound and outcome from surgery. Akt. Urol., 24: 127, 1993.